Apotex would challenge patents on brand-name drugs, and winning would allow it to be the first to offer a lower-price generic in the same market, enabling it to reap profits. ' WSJ Clever or corruption of copyright law?
-
-
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.